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Dear Sir,
In relation to our paper on plasma lead in poisoned subjects
(Rentschler et al. 2011), professor Sanaei-Zadeh asks
for additional information on three aspects: (1) laboratory
status regarding kidneys, liver, and bone marrow (2) our
deWnition of “severe poisoning”, and (3) treatment.
Ad (1): All Wve cases had serum creatinine concentrations
within the reference limits of our laboratory. Determination
of blood urea nitrogen is not a clinical routine in our depart-
ment. As regards serum transferases, case No. 3 had a
slight, transient rise initially [aspartate aminotransferase:
0.88 (upper reference limit 0.60) kat/L; alanine amino-
transferase: 1.1 (0.75) kat/L)], while all the others were
“normal”. Cases No. 1, 3, and 5 had typical microcytic
sideroblastic anemia in bone marrow biopsies. Only case
No. 5 was examined for basophilic stippling of erythrocytes
in peripheral blood; he displayed such.
Ad (2): We agree that our use of “severe” in some of the
present cases may not be fully justiWed, and “moderate”
may perhaps be more adequate for cases No. 1–4, while
No. 5 is “severe”. What we wanted to emphasize by using
the term severe is that we were not discussing the kind of
subclinical lead toxicity, which has been a major concern
during the last decades (Skerfving and Bergdahl 2007).
Ad (3): For several reasons, we did not administer chelat-
ing agents to the patients. All cases (even No. 5, who was
exposed in an occupational setting) had large amounts of
lead in their gastrointestinal tracts. Since oral chelation
therapy may increase the absorption of lead (Skerfving and
Bergdahl 2007), we avoided such. Moreover, the symptoms
and signs did not warrant intravenous therapy, in particular,
since the eVect of such on bioavailable lead is very tempo-
rary in subjects with a large bone-lead pool, which rapidly
reconstitutes lead in target organs by endogenous exposure.
Also, the clinical status improved signiWcantly soon after
the source of lead exposure had been located and the lead
intake was stopped.
At last, one more thing: Professor Sanaei-Zadeh men-
tions a whole-blood-lead level of 100 g/dL as typical for
severe lead poisoning. That touches upon one of the main
messages of our paper: Whole-blood lead at that level is
uninformative and may be very misleading, since there is
saturation. Caregivers may have a tendency to interpret the
level as rectilinearly related to exposure and tissue levels
which it is not. Hence, 100 g/dL may indicate either a
high or an extremely high exposure. Our data show that
plasma lead is much more informative at heavy exposure,
since it is rectilinearly related to exposure and tissue levels,
and is a valuable tool.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
Rentschler G, Broberg K, Lundh T, Skerfving S (2011) Long-term lead
elimination from plasma and whole blood after poisoning. Int
Arch Occup Environ Health. doi:10.1007/s00420-011-0673-0
Skerfving S, Bergdahl IA (2007) Lead. In: Nordberg GF, Fowler BA,
Nordberg M, Friberg LT (eds) Handbook on the toxicology of
metals, 3rd edn. Academic Press, New York, pp 599–643
G. Rentschler (&) · K. Broberg · T. Lundh · S. Skerfving
Division of Occupational and Environmental Medicine, 
Lund University, 221 85 Lund, Sweden
e-mail: Gerda.Rentschler@med.lu.se